Erythromycin DR 250mg Capsules

Manufacturer MAYNE Active Ingredient Erythromycin Delayed-Release Tablets and Capsules(er ith roe MYE sin) Pronunciation er ith roe MYE sin
It is used to treat or prevent bacterial infections.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antibiotic
đŸ§Ŧ
Pharmacologic Class
Macrolide antibiotic; Protein synthesis inhibitor
🤰
Pregnancy Category
Category B
✅
FDA Approved
Aug 1952
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Erythromycin is an antibiotic used to treat various bacterial infections, such as respiratory tract infections, skin infections, and some sexually transmitted infections. It works by stopping the growth of bacteria.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, unless your doctor advises you to take it differently. Swallow the medication whole - do not chew, break, or crush it. Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling well.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposing of your medication, consult your pharmacist. You may also want to check if there are drug take-back programs available in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take the medication exactly as prescribed by your doctor, even if you start to feel better. Do not skip doses or stop taking it early, as this can lead to antibiotic resistance.
  • Swallow the delayed-release capsules whole; do not crush, chew, or break them.
  • Take with a full glass of water.
  • Avoid taking with grapefruit juice, as it can increase the levels of erythromycin in your body.
  • Inform your doctor about all other medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins, as erythromycin can interact with many drugs.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 250 mg every 6 hours or 500 mg every 12 hours
Dose Range: 250 - 1000 mg

Condition-Specific Dosing:

Severe infections: Up to 4 g/day in divided doses
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established (use caution, specific dosing for neonates exists but varies by indication and weight)
Infant: 30-50 mg/kg/day in divided doses every 6-12 hours
Child: 30-50 mg/kg/day in divided doses every 6-12 hours (max 4 g/day)
Adolescent: 30-50 mg/kg/day in divided doses every 6-12 hours (max 4 g/day or adult dose)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed for most patients; consider dose reduction (e.g., 50% of usual dose) for severe impairment (CrCl <10 mL/min) if prolonged therapy or high doses are used, due to potential for accumulation and ototoxicity.
Dialysis: Not significantly removed by hemodialysis or peritoneal dialysis; administer after dialysis if dose adjustment is needed.

Hepatic Impairment:

Mild: Caution advised
Moderate: Dose reduction may be necessary; monitor liver function closely.
Severe: Contraindicated or significant dose reduction required; monitor liver function closely due to risk of hepatotoxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Erythromycin binds to the 50S ribosomal subunit of susceptible bacteria, thereby inhibiting RNA-dependent protein synthesis by blocking the translocation reaction. This action is primarily bacteriostatic, but can be bactericidal at high concentrations or against highly susceptible organisms.
📊

Pharmacokinetics

Absorption:

Bioavailability: 30-65% (highly variable depending on salt and formulation; delayed-release formulations improve bioavailability by protecting from gastric acid)
Tmax: 1-4 hours
FoodEffect: Delayed-release formulations (like capsules) are designed to minimize the food effect and can generally be taken without regard to meals, though some sources suggest empty stomach for optimal absorption.

Distribution:

Vd: 0.7 L/kg
ProteinBinding: 70-90%
CnssPenetration: Limited (poor penetration into CSF, even with inflamed meninges)

Elimination:

HalfLife: 1.5-2 hours
Clearance: Not available
ExcretionRoute: Primarily biliary/fecal (90-95%); <5% renal
Unchanged: <5%
âąī¸

Pharmacodynamics

OnsetOfAction: Rapid
PeakEffect: Within 1-4 hours (corresponds to Tmax)
DurationOfAction: Dependent on dosing interval (e.g., 6-12 hours)

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis), such as:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, or eyes
Difficulty urinating or changes in urine output
Severe dizziness or fainting
Rapid heartbeat
Abnormal heartbeat (long QT on ECG), which can be life-threatening. This risk may increase when taking other medications with this drug. Seek medical help immediately if you experience an irregular heartbeat.
Diarrhea, particularly a severe form called C. diff-associated diarrhea (CDAD), which can lead to life-threatening bowel problems. Contact your doctor right away if you experience:
+ Stomach pain
+ Cramps
+ Watery, bloody, or loose stools
Hearing loss, which is rare but may be more likely if you have kidney problems or take high doses of this medication. If you experience hearing problems, such as hearing loss, contact your doctor immediately.

Other Possible Side Effects

Most people do not experience severe side effects, but some may occur. If you notice any of the following symptoms or if they persist or bother you, contact your doctor:

Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite

This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe, watery diarrhea or bloody stools (may occur up to 2 months after stopping treatment)
  • Yellowing of the skin or eyes (jaundice)
  • Unusual tiredness or weakness
  • Dark urine
  • Severe stomach pain
  • Chest pain, fluttering in your chest, shortness of breath, or sudden dizziness (signs of heart rhythm problems)
  • Hearing loss or ringing in the ears (tinnitus)
  • Signs of a severe allergic reaction (rash, itching, swelling of face/tongue/throat, severe dizziness, trouble breathing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as:
+ Abnormal heartbeat patterns, including a prolonged QTc interval on an electrocardiogram (ECG)
+ Slow heartbeat
+ Low potassium or magnesium levels

Additionally, tell your doctor about all the medications you are currently taking, including:

Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins

This is crucial because some medications, such as those used to treat mood disorders, abnormal heart rhythms, or migraine headaches, may interact with this medication and should not be taken together.

It is not possible to list all the medications and health conditions that may interact with this drug. Therefore, it is vital to discuss all your medications and health problems with your doctor and pharmacist to ensure safe use.

Do not start, stop, or change the dose of any medication without first consulting your doctor to confirm it is safe to do so with this medication.
âš ī¸

Precautions & Cautions

Important Information for Patients Taking This Medication

It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

If you are taking this medication long-term, your doctor may recommend regular blood tests to monitor your condition. Be sure to discuss this with your doctor.

Please note that this medication may interfere with certain laboratory tests. It is essential to notify all of your healthcare providers and laboratory personnel that you are taking this medication.

Do not take this medication for longer than prescribed by your doctor, as this may increase the risk of a second infection.

If you are following a low-sodium or sodium-free diet, consult with your doctor before taking this medication, as some products may contain sodium.

If you have myasthenia gravis, it is essential to discuss your condition with your doctor. Monitor your symptoms closely, and contact your doctor immediately if they worsen. Additionally, be aware that myasthenia gravis symptoms, such as new or worsening muscle weakness, difficulty chewing or swallowing, breathing problems, droopy eyelids, or changes in vision (including blurred vision or double vision), can occur in people without a prior diagnosis of the condition. If you experience any of these symptoms, seek medical attention promptly.

Special Considerations

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

If you are pregnant, planning to become pregnant, or breastfeeding, consult with your doctor to discuss the potential benefits and risks to you and your baby.

Newborns

In rare cases, newborns taking this medication may develop a severe stomach condition. If your child vomits or becomes irritable during feeding, contact your doctor immediately.
🆘

Overdose Information

Overdose Symptoms:

  • Severe nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Hearing loss (reversible)
  • Liver dysfunction
  • Cardiac arrhythmias (rare)

What to Do:

In case of overdose, seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222). Treatment is supportive and symptomatic. Gastric lavage may be considered if ingestion is recent. Monitor cardiac function (ECG) and liver function.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Pimozide
  • Ergot alkaloids (e.g., ergotamine, dihydroergotamine)
  • Colchicine (in patients with renal or hepatic impairment)
🔴

Major Interactions

  • Statins (e.g., simvastatin, lovastatin, atorvastatin) - increased risk of rhabdomyolysis
  • Antiarrhythmics (e.g., amiodarone, disopyramide, dofetilide, dronedarone, procainamide, quinidine, sotalol) - increased risk of QT prolongation and Torsades de Pointes
  • Calcium channel blockers (e.g., verapamil, diltiazem, amlodipine, felodipine) - increased levels of CCBs, leading to hypotension, bradycardia
  • Warfarin - increased anticoagulant effect
  • Carbamazepine - increased carbamazepine levels, leading to toxicity
  • Theophylline - increased theophylline levels, leading to toxicity
  • Sildenafil, Tadalafil, Vardenafil - increased PDE5 inhibitor levels
  • Tacrolimus, Cyclosporine - increased immunosuppressant levels, leading to nephrotoxicity
  • Cisapride (removed from market in many countries due to QT prolongation)
  • Other drugs known to prolong QT interval (e.g., some antipsychotics, antidepressants, fluoroquinolones)
🟡

Moderate Interactions

  • Benzodiazepines (e.g., midazolam, triazolam) - increased sedation
  • Corticosteroids (e.g., methylprednisolone) - increased corticosteroid levels
  • Digoxin - increased digoxin levels
  • Phenytoin - altered phenytoin levels
  • Oral contraceptives - theoretical risk of reduced efficacy (though not consistently proven)
  • Zidovudine - decreased zidovudine levels
  • Clindamycin, Lincomycin, Chloramphenicol - antagonism of antibacterial effects
đŸŸĸ

Minor Interactions

  • Antacids (aluminum/magnesium hydroxide) - may reduce absorption of some erythromycin formulations (less relevant for DR)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Liver Function Tests (LFTs)

Rationale: To establish baseline for patients with pre-existing hepatic impairment or those on prolonged therapy, due to risk of hepatotoxicity.

Timing: Prior to initiation of therapy for at-risk patients.

Renal Function (CrCl)

Rationale: While not typically requiring dose adjustment, severe renal impairment may warrant caution and closer monitoring.

Timing: Prior to initiation for patients with known or suspected renal impairment.

📊

Routine Monitoring

Clinical response to therapy

Frequency: Daily

Target: Resolution of infection symptoms

Action Threshold: Lack of improvement or worsening symptoms may indicate treatment failure or resistance.

Signs and symptoms of hepatotoxicity (e.g., jaundice, dark urine, fatigue)

Frequency: Daily, especially during prolonged therapy

Target: Absence of symptoms

Action Threshold: Presence of symptoms warrants immediate discontinuation and LFTs.

Gastrointestinal adverse effects (e.g., nausea, vomiting, abdominal pain, diarrhea)

Frequency: Daily

Target: Tolerable or absent

Action Threshold: Severe or persistent GI upset may require dose reduction or discontinuation.

Electrocardiogram (ECG) for QT interval

Frequency: As clinically indicated, especially in patients with risk factors for QT prolongation or on concomitant QT-prolonging drugs.

Target: Normal QT interval (corrected QT <450 ms for men, <470 ms for women)

Action Threshold: Significant QT prolongation (>500 ms or increase >60 ms from baseline) warrants discontinuation and cardiac evaluation.

đŸ‘ī¸

Symptom Monitoring

  • Severe or persistent diarrhea (may indicate C. difficile-associated diarrhea)
  • Yellowing of skin or eyes (jaundice)
  • Dark urine
  • Unusual fatigue or weakness
  • Abdominal pain (especially right upper quadrant)
  • Chest pain, palpitations, irregular heartbeat, dizziness, fainting (signs of QT prolongation)
  • Hearing loss or tinnitus (rare, usually reversible ototoxicity)

Special Patient Groups

🤰

Pregnancy

Erythromycin is generally considered safe for use during pregnancy (Category B). Studies in pregnant women have not shown an increased risk of fetal abnormalities. It is often used as an alternative for penicillin-allergic pregnant women.

Trimester-Specific Risks:

First Trimester: No increased risk of congenital malformations observed.
Second Trimester: No specific risks identified.
Third Trimester: No specific risks identified.
🤱

Lactation

Erythromycin is excreted into breast milk in small amounts. It is generally considered compatible with breastfeeding (Lactation Risk Category L2 - Likely Compatible). Monitor breastfed infants for potential adverse effects such as diarrhea, candidiasis (thrush, diaper rash), or allergic reactions.

Infant Risk: Low
đŸ‘ļ

Pediatric Use

Erythromycin is widely used in pediatric patients. Dosing is weight-based. Caution is advised in neonates due to potential for infantile hypertrophic pyloric stenosis (IHPS), especially with erythromycin ethylsuccinate. Delayed-release formulations are generally not recommended for very young infants due to swallowing difficulties.

👴

Geriatric Use

No specific dose adjustment is required based solely on age. However, elderly patients may be more susceptible to QT prolongation and hearing loss, especially if they have pre-existing cardiac conditions, electrolyte imbalances, or renal/hepatic impairment. Monitor closely for adverse effects and drug interactions.

Clinical Information

💎

Clinical Pearls

  • Erythromycin is a potent CYP3A4 inhibitor, leading to numerous significant drug interactions. Always review concomitant medications carefully.
  • While generally well-tolerated, GI upset (nausea, vomiting, abdominal cramps) is a common side effect, especially with higher doses or non-enteric coated forms. Delayed-release formulations aim to reduce this.
  • Erythromycin can prolong the QT interval and should be used with caution in patients with known QT prolongation, uncorrected hypokalemia/hypomagnesemia, bradycardia, or those receiving other QT-prolonging drugs.
  • It is an effective alternative for patients with penicillin allergies, particularly for respiratory tract infections, skin infections, and atypical pneumonia.
  • Infantile hypertrophic pyloric stenosis (IHPS) has been reported in neonates receiving erythromycin, particularly erythromycin ethylsuccinate. Use with caution in this population.
🔄

Alternative Therapies

  • Other macrolides (e.g., azithromycin, clarithromycin)
  • Penicillins (e.g., amoxicillin, penicillin V)
  • Cephalosporins (e.g., cephalexin, cefdinir)
  • Tetracyclines (e.g., doxycycline)
  • Fluoroquinolones (e.g., levofloxacin, moxifloxacin)
  • Clindamycin
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 capsules (250mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide information about the medication taken, the amount, and the time it happened.